Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
0.50685
+0.0289 (6.04%)
Aug 18, 2026, 12:44 PM EDT - Market open
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $16.94 million as of August 18, 2026. Its market cap has increased by 223.79% in one year.
Market Cap
16.94M
Enterprise Value
-28.73M
1-Year Change
223.79%
Ranking
Category
Stock Price
$0.51
ChartMarket Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $16.94M, a decrease of -74.06%. That is a compound annual growth rate of -23.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 16.94M | -43.14% |
| Dec 31, 2025 | 29.79M | 646.69% |
| Dec 31, 2024 | 3.99M | -48.26% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
| Sep 15, 2021 | 65.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cyclerion Therapeutics | 17.46M |
| Palatin Technologies | 17.44M |
| Lipocine | 17.40M |
| Pluri | 17.26M |
| NeuroSense Therapeutics | 16.75M |
| Tempest Therapeutics | 16.22M |
| Vyome Holdings | 15.30M |
| Moolec Science | 14.98M |